Apoptosis has been reported to induce changes in the remodelling of membrane lipids; after death receptor engagement, specific changes of lipid composition occur not only at the plasma membrane, but also in intracellular membranes. This paper focuses on one important aspect of apoptotic changes in cellular lipids, namely, the redistribution of the mitochondria-specific phospholipid, cardiolipin (CL). CL predominantly resides in the inner mitochondrial membrane, even if the rapid remodelling of its acyl chains and the subsequent degradation occur in other membrane organelles. After death receptor stimulation, CL appears to concentrate into mitochondrial "raft-like" microdomains at contact sites between inner and outer mitochondrial membranes...
We have recently shown that cardiolipin (CL) and its metabolites move from mitochondria to other cel...
Recently, phospholipid peroxidation products gained a reputation as key regulatory molecules and par...
The pathogenesis of cardiovascular diseases (CVDs) is driven , in part , from impairment in myocar...
We previously reported that during death receptor-mediated apoptosis, cardiolipin (CL) relocates to ...
Cardiolipin (CL) is essential for the functionality of several mitochondrial proteins. Its distribut...
Cardiolipin (CL) is essential for the functionality of several mitochondrial proteins. Its distribut...
AbstractCardiolipin (CL) is a unique anionic phospholipid specific to the mitochondria. CL influence...
AbstractCardiolipin (CL) has recently been shown to provide an anchor and an essential activating pl...
Apoptosis is a highly programmed cell death strictly connected to the pathogenesis of many human dis...
AbstractApoptosis is an active and tightly regulated form of cell death, which can also be considere...
Apoptosis is an active and tightly regulated form of cell death, which can also be considered a stre...
Cardiolipin (CL) has recently been shown to provide an anchor and an essential activating platform f...
Recently, phospholipid peroxidation products gained a reputation as key regulatory molecules and par...
Cardiolipin (CL) is a tetra-acylated diphosphatidylglycerol lipid. In physiological conditions, CL p...
We have recently shown that cardiolipin (CL) and its metabolites move from mitochondria to other cel...
We have recently shown that cardiolipin (CL) and its metabolites move from mitochondria to other cel...
Recently, phospholipid peroxidation products gained a reputation as key regulatory molecules and par...
The pathogenesis of cardiovascular diseases (CVDs) is driven , in part , from impairment in myocar...
We previously reported that during death receptor-mediated apoptosis, cardiolipin (CL) relocates to ...
Cardiolipin (CL) is essential for the functionality of several mitochondrial proteins. Its distribut...
Cardiolipin (CL) is essential for the functionality of several mitochondrial proteins. Its distribut...
AbstractCardiolipin (CL) is a unique anionic phospholipid specific to the mitochondria. CL influence...
AbstractCardiolipin (CL) has recently been shown to provide an anchor and an essential activating pl...
Apoptosis is a highly programmed cell death strictly connected to the pathogenesis of many human dis...
AbstractApoptosis is an active and tightly regulated form of cell death, which can also be considere...
Apoptosis is an active and tightly regulated form of cell death, which can also be considered a stre...
Cardiolipin (CL) has recently been shown to provide an anchor and an essential activating platform f...
Recently, phospholipid peroxidation products gained a reputation as key regulatory molecules and par...
Cardiolipin (CL) is a tetra-acylated diphosphatidylglycerol lipid. In physiological conditions, CL p...
We have recently shown that cardiolipin (CL) and its metabolites move from mitochondria to other cel...
We have recently shown that cardiolipin (CL) and its metabolites move from mitochondria to other cel...
Recently, phospholipid peroxidation products gained a reputation as key regulatory molecules and par...
The pathogenesis of cardiovascular diseases (CVDs) is driven , in part , from impairment in myocar...